Divi’s Laboratories Limited on Wednesday, February 11, reported a mixed set of Q3FY26 numbers, with revenue and profit missing Street expectations, even as operating...
Emcure Pharmaceuticals reported a strong set of December-quarter earnings, with consolidated net profit jumping 50% year-on-year to ₹230.5 crore, aided by robust revenue growth...